Stoke Therapeutics, Inc.’s $163.3 Million Initial Public Offering

Davis Polk advised the representatives of the underwriters in connection with the transaction. Fenwick & West LLP advised Stoke Therapeutics on the deal. The Stoke Therapeutic…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now